Drug recall · April 1, 2015
Fentanyl Citrate Inj recall
Why: Failed Impurities/Degradation Specifications; 12 month stability testing.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Fentanyl Citrate Inj., USP, CII, 250 mcg/5 mL (50 mcg/mL) (0.05 mg/mL) 25 x 5 mL Single Dose Vials, For Intravenous or Intramuscular Use, Preservative Free, Rx Only, Manufactured by: West-Ward Pharmaceuticals, Eatontown, NJ 07724, NDC 0641-6028-25.
- Lots / codes
Lot #: 113312, Exp 11/2015; 014315 Exp 01/2016
- Quantity
- 445,475 Vials
- Company
- West-Ward Pharmaceutical Corporation, Cherry Hill, NJ
- Distribution
- Nationwide
- Initiated
- February 16, 2015 · Voluntary: Firm initiated
- Classified
- March 20, 2015
- Reported
- April 1, 2015
- Ended
- July 26, 2016
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Fentanyl
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.